Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to evaluate the efficacy of neoadjuvant QL1706 in participants with untreated T4N0 or Stage III (resectable), microsatellite instability high/ defective mismatch rep...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Qilu Pharmaceutical Co., Ltd.
NCT02595957 · Colon Cancer, Breast Cancer
NCT04450758 · Colon Cancer
NCT06746012 · Stage I Colon Cancer AJCC v8, Stage I Rectal Cancer AJCC v8, and more
NCT07494201 · Colorectal Cancer, Colon Cancer, and more
NCT05283330 · Cervical Cancer, Breast Cancer, and more
Affiliated Cancer Hospital of Sun Yat-sen University
Guangzhou
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions